Peripheral vascular remodeling in chronic heart failure: Clinical relevance and new conceptualization of its mechanisms

Journal of Cardiac Failure

Volumn 5, Issue 2, 1999, Pages 127-138

  Nakamura, Motoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Endothelium; Neurohormone; Nitric oxide

Indexed keywords

ADRENOMEDULLIN; CYTOKINE; NEUROHORMONE; NITRIC OXIDE;

ARTICLE; BLOOD VESSEL FUNCTION; ENDOTHELIUM CELL; EXERCISE; HEART AFTERLOAD; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE REMODELING; HUMAN; MUSCLE BLOOD FLOW; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULARIZATION;

EID: 0032993621     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(99)90035-0     Document Type: Review

References (110)

1. Zelis R, Mason DT: Diminished forearm arteriolar dilator capacity produced by mineralocorticoid-induced salt retention in man. Implications concerning congestive heart failure and vascular stiffness. Circulation 1970;41: 589-92
2. Zelis R, Delea CS, Coleman HN, Mason DT: Arterial sodium content in experimental congestive heart failure. Circulation 1970;41:213-6
3. Zelis R, Flaim SF: Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982;24: 437-59
4. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6
5. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5
6. Kangawa K, Matsuo H: Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 1984;118:131-9
7. Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 1988;32: 78-81
8. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-60
9. Wilson JR, Martin JL, Schwartz D, Ferraro N: Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984;69:1079-87
10. LeJemtel TH, Maskin CS, Lucido D, Chadwick BJ: Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 1986;74:245-51
11. Rosei EA, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, Bettoni G, Salvetti M, Muiesan P, Giulini SM: Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995;13:341-7
12. Jondeau G, Katz SD, Toussaint JF, Dubourg O, Monrad ES, Bourdarias JP, LeJemtel TH: Regional specificity of peak hyperemic response in patients with congestive heart failure: correlation with peak aerobic capacity. J Am Coll Cardiol 1993;22:1399-1402
13. Kraemer MD, Kubo SH, Rector TS, Brunsvold N, Bank AJ: Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol 1993;21: 641-8
14. Chiba M, Nakamura M, Kanaya Y, Kobayashi N, Ueshima K, Kawazoe K, Hiramori K: Improvement in lower limb vasodilatory reserve and exercise capacity in patients with chronic heart failure due to valvular heart disease. Eur Heart J 1997;18:1931-6
15. Sparks HV Jr, Belloni FL: The peripheral circulation: local regulation. Ann Rev Physiol 1978;40:67-92
16. Tyml K, Budreau CH: Heterogeneity of microvascular response to ischemia in skeletal muscle. Int J Microcirc Clin Exp 1988;7:205-21
17. Tyml K, Mathieu-Costello O, Budreau CH: Microvascular response to ischemia, and tissue structure, in normal and atrophied skeletal muscle. Microvasc Res 1990;39; 223-39
18. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA: Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996;270:H1435-40
19. Engelke KA, Halliwill JR, Proctor DN, Dietz NM, Joyner MJ: Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm. J Appl Physiol 1996;81:1807-14
20. Carlsson I, Sollevi A, Wennmalm A: The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperaemia. J Physiol 1987;389:147-61
21. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A: Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994;90:2285-90
22. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM: Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96
23. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, Zelis R: Endothelial function in chronic congestive heart failure. Am J Cardiol 1992;69:1596-601
24. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH: Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25
25. Hirooka Y, Imaizumi T, Harada S, Masaki H, Momohara M, Tagawa T, Takeshita A: Endothelium-dependent forearm vasodilation to acetylcholine but not to substance P is impaired in patients with heart failure. J Cardiovasc Pharmacol 1992;20:S221-5
26. Nakamura M, Ishikawa M, Funakoshi T, Hashimoto K, Chiba M, Hiramori K: Attenuated endothelium-dependent peripheral vasodilation and clinical characteristics in patients with chronic heart failure. Am Heart J 1994;128: 1164-9
27. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF: Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-9
28. Winlaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, Macdonald PS: Increased nitric oxide production in heart failure. Lancet 1994;344:373-4
29. Kubo SH, Rector TS, Bank AJ, Raij L, Kraemer MD, Tadros P, Beardslee M, Garr MD: Lack of contribution of nitric oxide to basal vasomotor tone in heart failure. Am J Cardiol 1994;73:1133-6
30. Katz SD, Krum H, Khan T, Knecht M: Exercise-induced Vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol 1996;28: 585-90
31. Habib F, Dutka D, Crossman D, Oakley CM, Cleland JG: Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet 1994;344:371-3
32. Yoshida H, Nakamura M, Akatsu T, Arakawa N, Hiramori K: Effects of nitric oxide inhibition on basal forearm blood flow in patients with non-ischemic chronic heart failure. Heat Vessels 1998;13:142-6
33. Maguire SM, Nugent AG, McGurk C, Johnston GD, Nicholls DP: Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent. Heart 1998;80:141-5
34. Carville C, Adnot S, Sediame S, Benacerraf S, Castaigne A, Calvo F, de Cremou P, Dubois-Rande J: Relation between impairment in nitric oxide pathway and clinical status in patients with congestive heart failure. J Cardiovasc Pharm 1998;32:562-70
35. Bank AJ, Rector TS, Tschumperlin LK, Kraemer MD, Letourneau JG, Kubo SH: Endothelium-dependent vasodilation of peripheral conduit arteries in patients with heart failure. J Card Fail 1994;1:35-43
36. Hayoz D, Drexler H, Munel T, Hornig B, Zeiher AM, Just H, Brunner HR, Zelis R: Flow-mediated arterial dilation is abnormal in congestive heart failure. Circulation 1993; 87:VII92-6
37. Hornig B, Arakawa N, Kohler C, Drexler H: Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;97: 363-8
38. Ramsey MW, Goodfellow J, Jones CJ, Luddington LA, Lewis MJ, Henderson AH: Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995;92:3212-9
39. Nakamura M, Chiba M, Ueshima K, Arakawa N, Yoshida H, Makita S, Funakoshi T, Hashimoto K, Ishikawa M, Hiramori K: Impaired cholinergic peripheral vasodilation and its relationship to hyperemic calf blood flow response and exercise intolerance in patients with chronic heart failure. Int J Cardiol 1995;48;139-46
40. Nakamura M, Chiba M, Ueshima K, Arakawa N, Yoshida H, Makita S, Kawazoe K, Hiramori K: Effects of mitral and/or aortic valve replacement or repair on endotheliumdependent peripheral vasorelaxation and its relation to improvement in exercise capacity. Am J Cardiol 1996; 77:98-102
41. Koller-Strametz J, Matulla B, Wolzt M, Muller M, Entlicher J, Eichler HG, Schmetterer L: Role of nitric oxide in exercise-induced vasodilation in man. Life Sci 1998;62: 1035-42
42. Wilson JR, Kapoor S: Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans. J Appl Physiol 1993;75:2740-4
43. Lang CC, Chombsky DB, Butler J, Kapoor S, Wilson JR: Prostaglandin production contributes to exercise-induced vasodilation in heart failure. J Appl Physiol 1997; 83:1933-40
44. Katz SD, Krum H, Khan T, Knecht M: Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol 1996;28: 585-90
45. Dyke CK, Proctor DN, Dietz NM, Joyner MJ: Role of nitric oxide in exercise hyperaemia during prolonged rhythmic handgripping in humans. J Physiol 1995;488: 259-65
46. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA: Contribution of endotheliumderived nitric oxide to exercise-induced vasodilation. Circulation 1994;90:2853-8
47. Kubota T, Imaizumi T, Oyama J, Ando S, Takeshita A: L-arginine increases exercise-induced vasodilation of the forearm in patients with heart failure. Jpn Circ J 1997; 61:471-80
48. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu XB, Kobari Y, Pritchard K Jr, Sessa WC, Hintze TH: Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 1996;78;58-64
49. Aoki N, Siegfried M, Lefer AM: Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am J Physiol 1989;256:H1509-12
50. McMurray J, McLay J, Chopra M, Bridges A, Belch JJ: Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1990;65;1261-2
51. Belch JJ, Bridges AB, Scott N, Chopra M: Oxygen free radicals and congestive heart failure. Br Heart J 1991;65: 245-8
52. Gold ME, Bush PA, Ignarro LJ: Depletion of arterial L-arginine causes reversible tolerance to endotheliumdependent relaxation. Biochem Biophys Res Commun 1989;164:714-21
53. Hornig B, Maier V, Drexler H: Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996;93:210-4
54. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, Yu J, Adams V, Niebauer J, Schuler G: Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998;98:2709-15
55. Wang J, Yi GH, Knecht M, Cai BL, Poposkis S, Packer M, Burkhoff D: Physical training alters the pathogenesis of pacing-induced heart failure through endothelium-mediated mechanisms in awake dogs. Circulation 1997; 96:2683-92
56. Hirooka Y, Imaizumi T, Tagawa T, Shiramoto M, Endo T, Ando S, Takeshita A: Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994; 90:658-68
57. Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH: Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996;93: 2135-41
58. Kanaya Y, Nakamura M, Kobayashi N: Effects of L-arginine on lower limb vasodilatory reserve capacity and exercise parameters in patients with chronic heart failure. Heart 1999;81:517-27
59. Satoh M, Nakamura M, Tamura G, Makita S, Segawa I, Tashiro A, Satodate R, Hiramori K: Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 1997;29:716-24
60. Adams V, Yu J, Mobius-Winkler S, Linke A, Weigl C, Hilbrich L, Schuler G, Hambrecht R: Increased inducible nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure. Biochem Mol Med 1997;61:152-60
61. Clozel M, Kuhn H, Hefti F: Effects of angiotensin-converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 1990;16: 532-40
62. Mombouli JV, Nephtali M, Vanhoutte PM: Effects of the converting enzyme inhibitor cilazaprilat on endotheliumdependent responses. Hypertension 1991;18:II22-9
63. Nakamura M, Funakoshi T, Yoshida H, Arakawa N, Suzuki T, Hiramori K: Endothelium-dependent vasodilation is augmented by angiotensin-converting enzyme inhibitors in healthy volunteers. J Cardiovasc Pharmacol 1992;20:949-54
64. Nakamura M, Funakoshi T, Arakawa N, Yoshida H, Makita S, Hiramori K: Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure. J Am Coll Cardiol 1994;24:1321-7
65. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshita A: Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension 1992;20:175-80
66. Jeserich M, Pape L, Just H, Hornig B, Kupfer M, Munzel T, Lohmann A, Olschewski M, Drexler H: Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure. Am J Cardiol 1995;76:1079-82
67. Hornig B, Kohler C, Drexler H: Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997;95:1115-8
68. Wroblewski H, Sindrup JH, Norgaard T, Haunso S, Kastrup J: Effects of orthotopic cardiac transplantation on structural microangiopathy and abnormal hemodynamics in idiopathic dilated cardiomyopathy. Am J Cardiol 1996; 77:281-5
69. Andreassen AK, Kvernebo K, Jorgensen B, Simonsen S, Kjekshus J, Gullestad L: Exercise capacity in heart transplant recipients: relation to impaired endothelium-dependent vasodilation of the peripheral microcirculation. Am Heart J 1998;136;320-8
70. Langille BL, O'Donnell F: Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium dependent. Science 1986;231:405-7
71. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC: Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998;101:731-6
72. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, Takeshita A: Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension 1995;26:957-62
73. Myers PR, Tanner MA: Vascular endothelial cell regulation of extracellular matrix collagen - role of nitric oxide. Arterioscler Thromb Vase Biol 1998;18:717-22
74. Teerlink JR, Clozel M, Fischli W, Clozel JP: Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J Am Coll Cardiol 1993;22:615-20
75. Nakamura M, Yoshida H, Arakawa N, Mizunuma Y, Makita S, Hiramori K: Endothelium-dependent vasodilatation is not selectively impaired in patients with chronic heart failure secondary to valvular heart disease and congenital heart disease. Eur Heart J 1996;17:1875-81
76. Lee P, Kubo SH, Rector TS, Bank AJ: Time course of endothelial dysfunction in patients with heart failure. Circulation 1997;96:1671 (abstr)
77. Zelis R, Mason DT, Braunwald E: A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 1968;47:960-70
78. Creager MA, Quigg RJ, Ren CJ, Roddy MA, Colucci WS: Limb vascular responsiveness to beta-adrenergic receptor stimulation in patients with congestive heart failure. Circulation 1991;83:1873-9
79. Lindsay DC, Holdright DR, Clarke D, Anand IS, Poole-Wilson PA, Collins P: Endothelial control of lower limb blood flow in chronic heart failure. Heart 1996;75: 469-76
80. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P: Cyto-kine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994;75:181-9
81. Weber KT: Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 1997;96:4065-82
82. Mulder P, Elfertak L, Richard V, Compagnon P, Devaux B, Henry JP, Scalbert E, Desche P, Mace B, Thuille ZC: Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol 1996;271:H469-77
83. Longhurst J, Capone RJ, Zelis R: Evaluation of skeletal muscle capillary basement membrane thickness in congestive heart failure. Chest 1975;67:195-8
84. Lindsay DC, Anand IS, Bennett JG, Pepper JR, Yacoub MH, Rothery SM, Severs NJ, Poole-Wilson PA: Ultrastructural analysis of skeletal muscle. Microvascular dimensions and basement membrane thickness in chronic heart failure. Eur Heart J 1994;15:1470-6
85. Wroblewski H, Kastrup J, Norgaard T, Mortensen SA, Haunso S: Evidence of increased microvascular resistance and arteriolar hyalinosis in skin in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:769-74
86. Wroblewski H, Norgaard T, Haunso S, Katrup J: Microvascular distensibility in two different vascular beds in idiopathic dilated cardiomyopathy. Am J Physiol 1995; 269:H1973-80
87. Kubo SH, Rector TS, Heifetz SM, Cohn JN: Alpha 2-receptor-mediated vasoconstriction in patients with congestive heart failure. Circulation 1989;80:1660-7
88. Indolfi C, Maione A, Volpe M, Rapacciuolo A, Esposito G, Ceravolo R, Rendina V, Condorelli M, Chiariello M: Forearm vascular responsiveness to alpha 1- and alpha 2-adrenoceptor stimulation in patients with congestive heart failure. Circulation 1994;90:17-22
89. Haywood GA, Gullestad L, Katsuya T, Hutchinson HG, Pratt RE, Horiuchi M, Fowler MB: ATI and AT2 angiotensin receptor gene expression in human heart failure. Circulation 1997;95:1201-6
90. Asano K, Dutcher DL, Port JD, Minobe WA, Tremmel KD, Roden RL, Bohlmeyer TJ, Bush EW, Jenkin MJ, Abraham WT, Raynolds MV, Zisman LS, Perryman MB, Bristow MR: Selective downregulation of the angiotensin II ATI-receptor subtype in failing human ventricular myocardium. Circulation 1997;95:1193-200
91. Burnett JC Jr, Kao PC, Hu DC, Heser DW, Heublein D, Granger JP, Opgenorth TJ, Reeder GS: Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986;231:1145-7
92. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Imura H: Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990;323:757-8
93. Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H: Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 1995;26;1424-31
94. Jougasaki M, Wei CM, McKinley LJ, Burnett JC Jr: Elevation of circulating and ventricular adrenomediullin in human congestive heart failure. Circulation 1995;92: 286-9
95. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R: Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-9
96. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ: Plasma endothelin in chronic heart failure. Circulation 1992;85;1374-9
97. Hirooka Y, Takeshita A, Imaizumi T, Suzuki S, Yoshida M, Ando S, Nakamura M: Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure. Circulation 1990;82:147-53
98. Nakamura M, Arakawa N, Yoshida H, Makita S, Hiramori K: Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure. Circulation 1994;90:1210-4
99. Nakamura M, Arakawa N, Yoshida H, Makita S, Niinuma H, Hiramori K: Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure. Am Heart J 1998;135:414-20
100. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, Kinoshita M: Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 1993;87:70-5
101. Hirata Y, Hirose S, Takata S, Takagi Y, Matsubara H: Down-regulation of atrial natriuretic peptide receptor and cyclic GMP response in cultured rat vascular smooth muscle cells. Eur J Pharmacol 1987;135:439-42
102. Cao L, Wu J, Gardner DG: Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor. J Biol Chem 1995;270;24891-7
103. Mukaddam-Daher S, Tremblay J, Fujio N, Koch C, Jankowski M, Quillen EW Jr, Gutkowska J: Alteration of lung atrial natriuretic peptide receptors in genetic cardiomyopathy. Am J Physiol 1996;271:L38-45
104. Ishizaka Y, Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T: Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994;200:642-6
105. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K: Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 1997;95:1214-21
106. Nakamura M, Arakawa N, Yoshida H, Funakoshi T, Chiba M, Abe Y, Makita S, Aoki H, Hiramori K: Increased plasma endothelin concentrations in patients with acute heart failure after myocardial infarction. Jpn Circ J 1993;57:371-8
107. Love MP, Haynes WG, Gray GA, Webb DJ, McMurray JJ: Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation 1996;94;2131-7
108. Krum H, Katz SD: Effect of endothelin-1 on exercise-induced vasodilation in normal subjects and in patients with heart failure. Am J Cardiol 1998;81:355-8
109. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O: Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 1995;346:732-6
110. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y: Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-5